Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|August 25, 2019
The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A ReviewDavid S Mathiesen, Jonatan I Bagger, Natasha C Bergmann, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2016
Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose InfusionAsger Lund, Jonatan I Bagger, Mikkel Christensen, et al.
Diabetes Care|June 16, 2014
Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trialSigne H Østoft, Jonatan I Bagger, Torben Hansen, et al.
European Journal of Endocrinology|August 9, 2021
MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatinMads R Andersen, Malte P Suppli, Jonatan I Bagger, et al.
Diabetes Care|April 1, 2018
Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared With NonsmokersMagnus F Grøndahl, Jonatan I Bagger, Asger Lund, et al.
Nutrients|September 29, 2020
Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 DiabetesAmelia K Fotheringham, Jonatan I Bagger, Danielle J Borg, et al.
Endocrine Connections|February 17, 2023
No effect of the turmeric root phenol curcumin on prednisolone-induced glucometabolic perturbations in men with overweight or obesityPernille H Hellmann, Jonatan I Bagger, Katrine R Carlander, et al.
Diabetes, Obesity & Metabolism|April 15, 2018
Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?Emilie S Andersen, Asger Lund, Jonatan I Bagger, et al.
Diabetes|December 27, 2021
Glucagon Clearance is Preserved in Type 2 DiabetesMagnus F G Grøndahl, Asger Lund, Jonatan I Bagger, et al.
Diabetes|October 27, 2021
Glucagon Clearance is Preserved in Type 2 DiabetesMagnus F G Grøndahl, Asger Lund, Jonatan I Bagger, et al.
Pageof 5